0001437749-20-019131.txt : 20200901
0001437749-20-019131.hdr.sgml : 20200901
20200901170847
ACCESSION NUMBER: 0001437749-20-019131
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200831
FILED AS OF DATE: 20200901
DATE AS OF CHANGE: 20200901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hanna John Walter JR
CENTRAL INDEX KEY: 0001781127
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36156
FILM NUMBER: 201155017
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERACYTE, INC.
CENTRAL INDEX KEY: 0001384101
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 205455398
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 243-6300
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: CALDEROME INC
DATE OF NAME CHANGE: 20061219
4
1
rdgdoc.xml
FORM 4
X0306
4
2020-08-31
0001384101
VERACYTE, INC.
VCYT
0001781127
Hanna John Walter JR
6000 SHORELINE COURT
SUITE 300
SOUTH SAN FRANCISCO
CA
94080
1
Chief Commercial Officer
Common Stock
2020-08-31
4
M
0
53
4
A
74687
D
Common Stock
2020-08-31
4
M
0
9000
14.34
A
83687
D
Common Stock
2020-08-31
4
M
0
8835
8.86
A
92522
D
Common Stock
2020-08-31
4
M
0
19336
6.45
A
111858
D
Common Stock
2020-08-31
4
M
0
9375
9.05
A
121233
D
Common Stock
2020-08-31
4
M
0
9844
5.98
A
131077
D
Common Stock
2020-08-31
4
S
0
55970
33.3674
D
75107
D
Common Stock
2020-08-31
4
S
0
473
33.7762
D
74634
D
Stock Option (right to buy)
4
2020-08-31
4
M
0
53
0
D
2023-02-04
Common Stock
53
0
D
Stock Option (right to buy)
14.34
2020-08-31
4
M
0
9000
0
D
2024-02-18
Common Stock
9000
0
D
Stock Option (right to buy)
8.86
2020-08-31
4
M
0
8835
0
D
2025-03-01
Common Stock
8835
2
D
Stock Option (right to buy)
6.45
2020-08-31
4
M
0
19336
0
D
2026-02-28
Common Stock
19336
2
D
Stock Option (right to buy)
9.05
2020-08-31
4
M
0
9375
0
D
2027-03-02
Common Stock
9375
10417
D
Stock Option (right to buy)
5.98
2020-08-31
4
M
0
9844
0
D
2028-03-01
Common Stock
9844
24063
D
The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2020.
Represents weighted average sales price. Sale prices for the transactions range from $32.72 to $33.71. Detailed information regarding the number of shares sold at each separate price will be provided to the
SEC, the issuer or a shareholder upon request.
Represents weighted average sales price. Sale prices for the transactions range from $33.77 to $33.81. Detailed information regarding the number of shares sold at each separate price will be provided to the
SEC, the issuer or a shareholder upon request.
The option is fully vested.
The option became exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
/s/ Keith Kennedy, as Attorney-in-fact
2020-09-01